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Song et al. [1], report a new case of a ho-
mozygous p.Leu72Arg mutation in exon 
3 of the luteinizing hormone β (LHB) 
gene leading to hypogonadism in a 
19-year-old male patient, which is one of 
only a handful of cases reported to date. 
As more physicians become aware of di-
agnosing luteinizing hormone (LH) defi-
ciency, an important point that remains 
unresolved is the issue of the best thera-
peutic strategy to offer to these patients.
In patients with LHB mutations, the 
absence of LH during post-natal life 
leads to the characteristic pathological 
features seen on testicular biopsy, includ-
ing immature Leydig cells, a reduction of 
Sertoli cells, hypomorphic seminiferous 
tubules, markedly decreased inhibin B, 
and low testicular volume. Although tes-
tosterone administration may induce vi-
rilization, it does not stimulate testicular 
development, as shown by Song et al. [1]. 
It has been suggested that gonadotropin 
treatment early after the diagnosis of hy-
pogonadotropic hypogonadism may sig-
nificantly improve the fertility potential 
of these patients through mimicking of 
the “mini puberty” state [2]. 
Our three male patients with docu-
mented LHB mutations that were treat-
ed with human chorionic gonadotropin 
(hCG) (Pregnyl, MSD, Brussels, Belgium) 
5,000 IU/week for nearly 2 years had 
virilization and testicular growth, and 
spermatogenesis can occur, although it 
is usually suboptimal [3-5]. Our initial 
male patient successfully underwent as-
sisted reproduction [4], and had recent-
ly a second child via the same method. 
Taking into account this experience and 
the available literature on this very rare 
disorder, we propose that young males 
with LH deficiency due to a documented 
LHB mutation should be initially treated 
with gonadotropins (hCG, recombinant 
LH) rather than testosterone, to pro-
mote Sertoli and Leydig maturation as 
well as to improve spermatogenesis and 
maximize the potential for fertility. 
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